Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 79, Issue 2, 1997, Pages 163-172

  Day, James H ^a   Briscoe, Maureen P ^a   Clark, Reginald H ^b   Ellis, Anne K ^a   Gervais, Pierre ^c  

^a KINGSTON GENERAL HOSPITAL   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c Nordic Merrell Dow Research   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASTEMIZOLE; CETIRIZINE; LORATADINE; TERFENADINE;

ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; ENVIRONMENTAL EXPOSURE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RAGWEED; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION;

EID: 0030763484     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63104-3     Document Type: Article

References (8)

1. Austen KF. Diseases of Immediate Type Hypersensitivity. In: Isselbacher KJ, Braunwald E, Wilson JD, et al., eds. Harrison's Principles of Internal Medicine 13th ed. New York: McGraw-Hill Inc., 1994:1630-1638.
2. Simons FER, McMillan JL, Simons KJ. A double-blind, single dose, cross-over comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990;86:540-7.
3. Day JH, Clark RH, Gow D, Gibson M. Controlled pollen exposure - a new method of assessing drug efficacy (abstract). In: N Engl Reg Allergy Proc 1988;9(4):298.
4. Day JH, Clark RH, Briscoe M, Dhillon M. Controlled pollen challenge is valuable in the assessment of anti-allergic medications (abstract). Clin Invest Med 1991;14(4):A5.
5. Donovan JP, Buckeridge DL, Briscoe MP, et al. Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure. Ann Allergy Asthma Immunol 1996;77:74-80.
6. Day JH, Clark RH, Briscoe M, Dhillon M. Mass pollen provocation as a screen for entry into a study of the efficacy of aqueous budesonide for seasonal allergic rhinitis (abstract). Ann Allergy 1991;66:66.
7. Day JH, Briscoe MP, Ploscowe VB, Freeman GB. Controlled pollen exposure for assessing efficacy of ophthalmic antihistamine/decongestant solutions for allergic conjunctivitis (abstract). Clin Invest Med [Suppl] 1992;15(4):A7.
8. Day JH, Briscoe MP, Buckeridge D, et al. A randomized, double-blind, placebo-controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996; 97:1050-7.